Excision and Primary Anastomosis for Short Bulbar Strictures: Is It Safe to Change from the Transecting towards the Nontransecting Technique?

Table 4

Characteristics and surgical outcomes of patients treated by tEPA and ntEPA in the intention-to-treat ntEPA cohort (IQR: interquartile range; FFS: failure-free survival; ITT-tEPA: intention-to-treat transecting excision and primary anastomosis; ITT-ntEAP: intention-to-treat nontransecting excision and primary anastomosis; NA: not available).

	tEPA (n=11)	ntEPA (n=88)	p-value
follow-up (months); median (IQR)	36 (23-73)	32 (17-57)	0,308
age (years); median (IQR)	44 (36-52)	47 (30-64)	0,676
stricture length (cm); median (IQR)	2 (1,25-2,5)	1,25 (1-2)	0,019
diabetes; n(%)	0 (0%)	5 (5,7%)	1
presence of suprapubic catheter; n(%)	3 (27,3%)	15 (17%)	0,415
previous urethroplasty; n(%)	4 (36,5%)	18 (20,5%)	0,256
operation time (minutes); median (IQR)	115 (88-158)	87 (71-100)	0,01
hospital stay (days); median (IQR)	2 (2-3)	2 (1-2)	0,088
extravasation at first cystography; n(%)	2 (18,2%)	6 (6,8%)	0,217
catheterization time (days); median (IQR)	15 (12-15)	9 (8-13)	0,005
failure; n(%)	1 (9,1%)	6 (6,8%)	0,574
complications; n(%)
none	8 (72,7%)	70 (79,5%)	0,339
G1	1 (9,1%)	12 (13,6%)
G2	2 (18,2%)	5 (5,7%)
G3	0 (0%)	1 (1,1%)